Livento Group Enters Material Definitive Agreement
Ticker: LIVG · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1593549
| Field | Detail |
|---|---|
| Company | Livento Group, Inc. (LIVG) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, definitive-agreement
TL;DR
Livento Group signed a big deal on Oct 1, 2025. Details TBD.
AI Summary
On October 1, 2025, Livento Group, Inc. entered into a material definitive agreement. The filing does not provide specific details about the agreement, its counterparty, or any associated financial terms.
Why It Matters
This filing indicates a significant new development for Livento Group, Inc., though the lack of detail leaves investors uncertain about the nature and impact of the agreement.
Risk Assessment
Risk Level: medium — The lack of specific details regarding the material definitive agreement introduces uncertainty and potential risk for investors.
Key Players & Entities
- Livento Group, Inc. (company) — Registrant
- October 1, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- NuGene International, Inc. (company) — Former Company Name
- Bling Marketing, Inc. (company) — Former Company Name
FAQ
What is the nature of the material definitive agreement entered into by Livento Group, Inc.?
The filing states that Livento Group, Inc. entered into a material definitive agreement on October 1, 2025, but does not provide specific details about its nature.
Who is the counterparty to this material definitive agreement?
The filing does not disclose the name of the other party involved in the material definitive agreement.
What are the key financial terms or obligations associated with this agreement?
The filing does not specify any financial terms, dollar amounts, or obligations related to the material definitive agreement.
When was the material definitive agreement entered into?
The material definitive agreement was entered into on October 1, 2025.
Does this agreement represent a significant change in Livento Group's business operations?
As a 'material definitive agreement,' it is presumed to be significant, but the filing lacks the specifics to confirm the exact impact on business operations.
Filing Stats: 335 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2025-10-01 06:03:53
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUGN OTC Pink
Filing Documents
- form8-k.htm (8-K) — 28KB
- 0001493152-25-016442.txt ( ) — 185KB
- nugn-20251001.xsd (EX-101.SCH) — 3KB
- nugn-20251001_lab.xml (EX-101.LAB) — 33KB
- nugn-20251001_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2025 Livento Group, Inc. (Exact name of registrant as specified in its charter) Nevada 000-56457 49-3999052 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) File Number) Identification No.) 17 Stete Street , Suite 4000 NY 10004 (Address of Principal Executive Office) (Zip Code) 980 - 432-8241 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share NUGN OTC Pink Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01. Entry into a Material Definitive Agreement. On September 5, 2025 the company issued 40,000,000 as a settlement for 2022 liability that was assigned to Conelia Management LTD on August 20, 2025. /s/ David Stybr David Stybr President Livento Group Inc. (formerly NuGene International, Inc.)